Centaur Pharmaceuticals
Focus: Centaur Pharmaceuticals is an India-based small molecule and API manufacturer founded in 1996, specializing in generics and neurology-focused therapeutics. The company operates primarily in the post-patent-expiration generic market with limited visible pipeline development.
Profile data last refreshed 14h ago · AI intelligence enriched 3w ago
Open Jobs
0
About Centaur Pharmaceuticals
AI assessmentNot HiringNo open roles listed right now. Follow Centaur Pharmaceuticals to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Centaur Pharmaceuticals's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
4 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Post-LOE
ANDA-approved generic antiepileptic; post-patent-expiration product with multiple redundant filings suggesting market saturation.
Help build intelligence for Centaur Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.